The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which will retain 20% equity in the new company.
His disruptive, hard-power style has allies making concessions and sharing burdens.
Most of the company’s management employees will be required to report to the office three days a week.
Trump may help nations rediscover their economic vigor, martial strength and sense of national purpose.
Trump Administration aims to soften the blow by negotiating with insurers.
Commerce Department officials are discussing a new fee based on patent value, which could fuel backlash from businesses.
Shareholders in Wise, a rare U.K. tech success, voted in favor of moving its main stock listing to New York and extending dual-class shares by a decade.
Hollywood stars assist tech firm stung by concert public-relations crisis.
Hollywood stars assist tech firm stung by concert public-relations crisis.
The president described the food crisis in the enclave as a “terrible situation,” and said the U.S. would set up food centers and fund the effort along with European nations.
Europe has pledged to increase purchases of American energy but exporters may struggle to meet demand.
Find insight on the tariff deal between the U.S. and EU and more in the latest Market Talks covering Health Care.
The chips will be designed for AI data centers, autonomous driving and robots. Shares in the South Korean tech giant surged.
Japan is playing down the risks from its deal after the White House said the U.S. would direct $550 billion in investments by Japan and keep 90% of the profit.
America is the only freedom-loving nation on earth able to provide enough armaments to defeat Russia.